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Antiphospholipid antibody syndrome (APS) is a rare
condition in childhood. Some cases have been reported
in neonates, and it is believed that most of them result
from a transplacental transfer of antiphospholipid anti-
bodies (APLA) from the mother to the foetus.
Case
the first child of a 28 year healthy mother with no his-
tory of auto-immunity nor thrombotic events. The preg-
nancy was complicated by diabetes. The birth arose
after a 39 weeks pregnancy, by normal vaginal delivery.
The male newborn weighted 3830 g (P90). The clinical
examination was normal. The third day, he exhibited
clonic seizure of the right hemi-body. EEG demon-
strated left temporal spikes. Cerebral ultrasonography
and MRI showed infarction in the territory of the left
middle cerebral artery. Prothrombin time and activated
partial thromboplastin time, antithrombin III, protein C,
protein S and homocystine levels were normal. There
was no mutation of the factor II or V. Serology for anti-
phospholipid antibodies and detection for antib2gp1
were negative in the child and the mother serum. One
year later, a new systematic screening showed a high
titer of anticardiolipid antibodies (Table 1). Antinuclear
antibodies were negative. None of those antibodies were
found in the maternal serum. All those features per-
sisted on a second testing 12 weeks later.
Conclusion
Contrary to what is usually thought, neonatal APS not
always result from the transplacental transfer of APLA.
Our case highlights the importance of considering the
maternal status when reporting on neonatal APS; and of
considering the possibly of APS even in the absence of
antibodies in the mother.
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Table 1 Biological features of the child and the mother
Time after birth
5 days 1 year
Normal values Child Mother Child Mother
KCT (sec) 43/34 52/35 36/36
Anticardiolipid AB IgM (UMPL/ml) <10 <5 <1 4 <1
IgG (UGPL/ml) <11 <5 <1 191 <1
Anti b2gpI AB IgM <10 <5 <1 <1 <1
IgG <20 <5 <1 258 <1
VDRL - - NEG NEG
TPHA - NEG NEG
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